14th International Symposium on Myelodysplastic Syndromes - 3-6 May 2017

Grants available for the upcoming 14th International Symposium on MDS – May 3-6 2017.

The committee is pleased to announce the winners for 2017.

Matthew Cullen and Anna Gibson each grant will be for € 2000.

The winner of the EHA award 2015

Simona Valleta

Simona Valleta

Winning Scientist - Simona Valletta, LLR Molecular Haematology Unit, Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, John Radcliffe Hospital, Oxford, UK

Abstract title:Correction Of Mutations Of The Epigenetic Modifier ASXL1 In Myeloid Leukemia Cells By CRISPR/Cas9 Genome Editing.

The two winners of the EHA award 2014

Elena Crisa


Winning clinician - Elena Crisa, Honorary Clinical Research Fellow, Department of Haematology Research, King's College Hospital NHS Foundation Trust, London/Abstract title: Isolated total monosomy 7 is associated with better prognosis in a large cohort of MDS patients compared with other abnormalities of chromosome 7 - a single institute experience.



Andrea Pellagatti

>Andrea Pellagatti

Winning Scientist - Andrea Pellagatti, LLR Molecular Haematology Unit, Nuffield Division of Clinical Lab Sciences, University of Oxford/Abstract title: Comprehensive analysis of mutation status, gene expression profiles, blood and bone marrow counts and outcome in patients with myelodysplastic syndromes.

IPSS-R MDS Risk Assessment Calculator

Revised International Prognostic Scoring System (IPSS-R) for Myelodysplastic Syndromes Risk Assessment Calculator


Click here

MDS Fact Sheet

MDS Factsheet for GPs General Practicioners


Click here

Varicella Vaccine in MDS

Urgent Clarification on varicella vaccine policy

Current advice from the UK MDS Forum is not to give the Live Varicella Vaccine to patients with MDS.

Please read below correspondence between Professor Salisbury and Dr George Follows, the latter on behalf of the CLL Forum, on the varicella vaccine policy.
This is an external link to the British Society for Haematology  Click here

NICE Guideline

Lenalidomide for treating myelodysplastic syndromes (MDS) associated with an isolated deletion 5q cytogenetic abnormality.

NICE logo

Click here

BCSH Guideline

This is an external  link to the home of the British Society for Haematology (BSH). 

bsh logo

Click here